Next Article in Journal
Is Immunotherapy Beneficial in Patients with Oncogene-Addicted Non-Small Cell Lung Cancers? A Narrative Review
Next Article in Special Issue
A Meta-Analysis and Review of Radiation Dose Escalation in Definitive Radiation Therapy between Squamous Cell Carcinoma and Adenocarcinoma of Esophageal Cancer
Previous Article in Journal
Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer
Previous Article in Special Issue
Treatment Outcomes and Risk Factors for Incomplete Treatment after Definitive Chemoradiotherapy for Non-Resectable or Metastatic Esophageal Cancer
 
 
Article

Article Versions Notes

Cancers 2024, 16(3), 529; https://doi.org/10.3390/cancers16030529
Action Date Notes Link
article xml file uploaded 26 January 2024 07:23 CET Original file -
article xml uploaded. 26 January 2024 07:23 CET Update https://www.mdpi.com/2072-6694/16/3/529/xml
article pdf uploaded. 26 January 2024 07:23 CET Version of Record https://www.mdpi.com/2072-6694/16/3/529/pdf
article html file updated 26 January 2024 07:25 CET Original file -
article html file updated 24 June 2025 09:58 CEST Update https://www.mdpi.com/2072-6694/16/3/529/html
Back to TopTop